液基薄层技术结合TBS法在宫颈病变中的诊断价值

The value of LiquidPrep Test and the Bethesda System reporting for cervical cancer and intraepithelial neoplasia diagnosis

目的探讨液基薄层制片技术对宫颈癌及宫颈上皮内肿瘤的诊断价值。方法对7567例患者进行宫颈液基薄层细胞学检查,筛查出鳞状上皮细胞异常655例,其中528例行阴道镜下取活检,并进行组织病理学检查。结果 528例鳞状上皮细胞异常细胞学与组织病理学对照结果显示,低级别鳞状上皮内病变(LSIL)93.61%(132/141),高级别鳞状上皮内病变(HSIL)96.78%(60/62),4例鳞状细胞癌均符合。结论应用液基薄层细胞制片技术,能准确掌握TBS的诊断标准,对确保宫颈癌及宫颈上皮内肿瘤的检出率具有重要的临床价值。

Objective To discuss the LiquidPrep Test（LTP） and The Bethesda System（TBS） reporting on cervical cancer and Cervical intraepithelial neoplasia diagnosis.Methods By cervical cytology liquid-based thin-layer on 7567 cases were analyzed and 655 cases were squamous cell abnormalities,included 528 regular colposcopic biopsy,and histopathological diagnosis of the control group.Results 528 cases of squamous cell abnormal cytology and biopsy results were low-grade squamous intraepithelial lesions（LSIL） was 93.61%（132/141）,high grade squamous intraepithelial lesions（HSIL） was 96.78%（60/62）,4 cases squamous cell carcinoma were found.Conclusion High accuracy of diagnosis in TBS by using liquid based cytology technique,to enhance detection rate in cervical cancer and cervical intraepithelial neoplasia.